Thirst for drink brands

A £1 billion ($1.4 billion) bidding war for Lucozade and Ribena is brewing with a raft of private equity firms considering offers. Pharmaceutical giant GlaxoSmithKline last month signalled it wanted to offload the brands.

A £1 billion ($1.4 billion) bidding war for Lucozade and Ribena is brewing with a raft of private equity firms considering offers. Pharmaceutical giant GlaxoSmithKline last month signalled it wanted to offload the brands.